Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion type Assertion NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_head.
- NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion description "[The candidacy of the CHRD and GSC genes was supported by several lines of evidence: prior evidence for a CDLS gene at 3q26.3-q27; a report suggesting a significant association between CDLS and thrombocytopenia; suspected genetic heterogeneity in CDLS; location of the GSC gene in close proximity to a 14q32 breakpoint detected in a CDLS patient with a balanced de novo translocation; known regulation of chordin expression by goosecoid; and the pattern of embryonic expression of the mouse GSC gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_provenance.
- NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion evidence source_evidence_literature NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_provenance.
- NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion SIO_000772 10480362 NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_provenance.
- NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion wasDerivedFrom befree-20140225 NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_provenance.
- NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_assertion wasGeneratedBy ECO_0000203 NP283750.RAJJ2hZsC3HYgoQYwswTMhwSgvLZv_AyMaHt9XElb2M0I130_provenance.